NCT02490735View on ClinicalTrials.gov

CIK in Treating Patients With Esophageal Cancer

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

2,000

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

August 31, 2040

Study Completion Date

August 31, 2042

Conditions
Esophageal Squamous Cell Carcinoma
Interventions
BIOLOGICAL

Cytokine-induced Killer Cells

chemotherapy plus 3 cycles of Cytokine-induced Killer Cells(CIK) treatment

All Listed Sponsors
lead

The First People's Hospital of Changzhou

OTHER

NCT02490735 - CIK in Treating Patients With Esophageal Cancer | Biotech Hunter | Biotech Hunter